VIPER® Technology enables us to produce scalable, reliable, affordable, easy-to-use and fast detection solutions.
Preventing bacterial, viral & fungal contamination is key to sustaining healthy living
We are a privately held life science company based in The Netherlands, which has developed a novelle and disruptive bacterial, viral and fungal detection platform technology named VIPER®.
VIPER® is genuinely innovative, highly sensitive, specific and fast (seconds - minutes) that lends itself to application development in healthcare and food.
The Detact Management team (below) is very experienced in medicine, surgery, clinical chemistry, microbiology, chemical engineering, patent law and all commercial aspects of bringing diagnostic tests to market.
Detact Diagnostics Core Innovation Team, led by CTO Matthew Burton, includes Simone Savino, PhD and Marleen Kalk.
Our extended team includes experts from various fields, such as clinical microbiologists, medical advisors, QA advisors and scientific advisors, to name a few.
was trained as a European Certified Trauma Surgeon, received his PhD in collaboration with PENN University, and left the clinical field to found Detact Diagnostics.Contact me
is a PhD chemical biologist; after completing his study, he continued to expand on his skill set, became a fully trained (Certified) European Patent Attorney.Contact me
is a Master of Science in pharmacy. After a career with several business development functions in the Groningen life science sector. Hedi is responsible for operations & quality management.Contact me
“Identifying bacterial, viral or fungal presence on site enables healthcare providers and the food processing industry to be pro-active and prevent an outbreak rather than deal with the consequence of after the fact. Detecting harmful bacteria, viruses or fungal proteases with a quick-test would reduce the likelihood of an outbreak” - Joost Gazendam, CEO Detact Diagnostics®.
We are always interested in working and collaborating with medical centres & companies where we can apply our innovative platform VIPER® technology to solve a particular bacterial, viral or fungal problem you may be facing.
To discuss your project, feel free to get in touch at:
During the global health Pandemic caused by COVID-19, our sister company ViroTact© was created, focusing on developing a quick, easy-to-use, point-of-care test to identify COVID-19 using VIPER® Technology.
ViroTact© will continue focusing on the crucial work of developing viral detection diagnostics utilising VIPER® technology, ready for any future issues we may encounter.
GENERAL CONDITIONS OF SUPPLY